In8bio financial statements

이네이트바이오NASDAQ:INAB · Nasdaq · Healthcare · sector #17
$1.39-2.11%
2026-10-06 close

In8bio's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$31M.

Reported results

In8bio notifications

Quantus Signal · live data · not investment advice · Privacy Policy